Search Results - anti-inflammatory+pharma

5 Results

Sort By:

Use of delta 8 THC to treat inflammatory and autoimmune diseases

Reference #: 01583 The University of South Carolina is offering licensing opportunities for Use of delta 8 THC to treat inflammatory and autoimmune diseases Background: There are millions of people who suffer from debilitating inflammatory and autoimmune diseases against which there is no cure. Delta-8 THC is present in small quantity in cannabis...

Published: 10/26/2023 | Inventor(s): Prakash Nagarkatti, Mitzi Nagarkatti, Khadija Kakar

Keywords(s): anti-inflammatory biotech, anti-inflammatory pharma, autoimmune diseases, cannabinoids, inflammation

Category(s): Biomedical and Life Sciences, Health Sciences

Blood-cytokine levels as adverse outcome predictors following biomaterial implant surgery

Reference #: 01566 The University of South Carolina is offering licensing opportunities for Blood-cytokine levels as adverse outcome predictors following biomaterial implant surgery Background: Despite the high number of patients undergoing reconstruction surgery with surgical mesh and the relatively high number of adverse outcomes, there are currently...

Published: 9/26/2023 | Inventor(s): Melissa Moss, Mihyun Waugh, Nicholas Boltin, Lauren Wolf, Ronnie Horner, Matthew Hermes, Thomas Wheeler, Richard Goodwin

Keywords(s): anti-inflammatory biotech, anti-inflammatory pharma, biomaterial implant, Blood samples, cytokines, implant rejection, inflammation, pelvic organ prolapse, plasma, predictive outcome, principal component analysis, surgical mesh

Category(s): Health Sciences

Luteolin for treatment of neuromuscular movement disorder dystonia 16 (DYT16)

Reference #: 01544 The University of South Carolina is offering licensing opportunities for Luteolin for treatment of neuromuscular movement disorder dystonia 16 (DYT16) Background: DYT16 is a rare movement disorder, so the number of patients worldwide is small. However, Alzheimer's disease, Down syndrome are very prevalent and large numbers...

Published: 12/20/2023 | Inventor(s): Rekha Patel

Keywords(s): anti-inflammatory pharma, dystonia, DYT16, inflammation, movement disorder, PACT, PKR

Category(s): Biomedical and Life Sciences, Health Sciences

Immune CB1 Activation for Obesity Therapy

Reference #: 01478 The University of South Carolina is offering licensing opportunities for Immune CB1 activation for obesity therapy Background: The endocannabinoid system regulates various physiological processes such as inflammation and metabolism, and is comprised of cannabinoid receptors, CB1 and CB2, as well as their ligands called endocannabinoids....

Published: 11/29/2023 | Inventor(s): Prakash Nagarkatti, Mitzi Nagarkatti, Kathryn Miranda

Keywords(s): anti-inflammatory pharma, cannabinoids, CB1, inflammation, metabolic syndrome, Obesity, weight loss

Category(s): Health Sciences, Biomedical and Life Sciences

Natural Compounds for Modulation of Cell Secretome Production and Composition

Reference #: 01421 The University of South Carolina is offering licensing opportunities for Natural Compounds for Modulation of Cell Secretome Production and Composition Background: Plants are the oldest source of natural compounds with medicinal and cosmetic properties explored by the world. 11% of the existed essential drugs used in modern human...

Published: 8/9/2023 | Inventor(s): Ehsan Jabbarzadeh, Maria Yanez, Sara Eslambolchimoghadam

Keywords(s): anti-inflammatory, anti-inflammatory biotech, anti-inflammatory pharma, catalyzing stem cell secretome, cell-free therapy, chronic wound treatment, condition media, natural, Natural product, regenerative therapy

Category(s): Biomedical and Life Sciences, Health Sciences